Randomized control study to evaluate the efficacy of adjuvant androgen deprivation therapy after rotational IMRT in patients with high risk prostate cancer - Randomized control study to evaluate the efficacy of adjuvant androgen deprivation therapy after rotational IMRT in patients with high risk prostate cancer

The University of Tokyo Hospital0 个研究点目标入组 200 人开始时间: 2012年9月10日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.Clinical stage T3b or T4 2.Patients who has metastasis with lymph node or distant lesion 3.Patients with active another cancer 4.Patients with uncontrollable hypertension 5.Patients with severe psychiatric disorders 6.Patients with connective tissue disease 7.Patients with poorly controlled diabetes 8.Patients with poorly controlled ischemic heart disease 9.Patients who had prior surgery for prostate (e.g. radical prostatectomy) 10.Patients who had prior radiotherapy (e.g. EBRT, brachytherapy) 11.Patients who had prior orchiectomy 12.Patients who are treated with steroids (except for external use for skin) 13.Patients who are treated with anti-androgen for BPH 14.Patients who considered inappropriate for this trial by physicians

发起方